Cerebral Oxygen Monitoring During Surgery and Recovery After Surgery in Patients Having Lung Surgery (NCT01835327) | Clinical Trial Compass
TerminatedNot Applicable
Cerebral Oxygen Monitoring During Surgery and Recovery After Surgery in Patients Having Lung Surgery
Stopped: PI no longer at institution
United States130 participantsStarted 2012-09
Plain-language summary
The current study proposes to address the question of whether patients' cerebral oxygen saturation levels are predictive of their recovery from thoracic surgery. Further, the study poses the hypothesis that a patient's poor recovery status goes on to increase a patient's risk of developing post-operative morbidities such as pneumonia, arrhythmias and delirium. The aim of this study is to address the observation that some patients struggle more than others in their recovery and that 1) this may be a result of intraoperative cerebral oxygen desaturations and 2) that this may affect their post-operative morbidity. If a potential means of predicting poor outcomes is identified this will lead to further research into how to adjust the associated variables, such as cerebral oxygenation, to improve patient post-operative outcome.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* speak English
* 18 yo or older
* willing to participate
* undergoing thoracic surgery at Mount Sinai Hospital that will require one lung ventilation
Exclusion Criteria:
* prisoners
* lack capacity to consent to trial
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial was terminated before completing — do you know why it was stopped, and does that affect what we can actually learn from its findings about cerebral oxygen monitoring during lung surgery?
2Since this study was looking at cerebral oxygen desaturation during and after lung surgery, is monitoring my brain oxygen levels something that could or should be done during my procedure, even outside of a research setting?
3The trial was measuring quality of recovery and post-operative morbidity after lung surgery — based on whatever data was collected before it was terminated, is there anything useful that has been published or shared that might inform my care?
4Because this trial was terminated and wasn't a specific phase testing a new drug or device approval, what does that mean for the strength of evidence around cerebral oxygen monitoring — and is it considered standard practice at your hospital?
5Given that the study focused on recovery quality after lung surgery, what signs of post-operative problems should I or my family watch for, and how does your team currently monitor for issues like reduced brain oxygen during and after my operation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.